Global Markets on Infectious Diseases

Any discussion of the business case for infection control (IC) must start by acknowledging that the single most important reason for IC is to prevent morbidity and mortality associated with nosocomial infections. Each year, hundreds and thousands of Americans suffer the consequences of nosocomial infections which can be ranging from the inconvenience of taking extra medications to death. Beyond the human cost is the important economic burden that these infections place on society, including not only the obvious increase in health care resource use but also indirect costs associated with the loss of productivity of patients and their caregivers.

  • Mechanism of action of virus
  • Prevention and control of virus
  • Rabies
  • Malaria, Dengue fever, River blindness
  • Available vaccines

Related Conference of Global Markets on Infectious Diseases

August 24-24, 2022

3rd International Conference on Immunology & Immunotherapies

Singapore City, Singapore
September 16-16, 2022

4th World Conference on Vaccine and Immunology

Osaka, Japan
September 16-17, 2022

International Conference on Immunology Research

New York, USA
November 17-18, 2022

World Congress on Infectious and Contagious Disease

Berlin, Germany
February 20-21, 2023

Global Summit on SARS-CoV-2 virus

Madrid, Spain
February 21-22, 2023

4th European Congress on Hematology

Zurich, Switzerland
May 24-25, 2023

37th International Conference on Immunology

Vienna, Austria

Global Markets on Infectious Diseases Conference Speakers

Recommended Sessions

Related Journals

Are you interested in